Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04088071 · ClinicalTrials.gov registry record
Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation
A clinical trial of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation, sponsored by Heart Rhythm Clinical and Research Solutions.
- Recruiting
- Registry status
- 15,000
- Enrollment target
- 20
- Study locations
NCT04088071: Recruiting study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation, sponsored by Heart Rhythm Clinical and Research Solutions.
NCT04088071 is a study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation that is actively recruiting participants, run by Heart Rhythm Clinical and Research Solutions. The registered enrollment target is 15,000 participants, above the 234-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (6310% higher). The trial reports 20 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04088071, a study of Paroxysmal Atrial Fibrillation and Persistent Atrial Fibrillation, is actively recruiting participants, sponsored by Heart Rhythm Clinical and Research Solutions.
- RECRUITING
- Registry status
- 15,000 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary purpose of this registry is to obtain real-world clinical experience of Paroxysmal (PAF) and Persistent (PsAF) Atrial Fibrillation ablation radiofrequency (RF) technologies. Data from the registry will be used to assess clinical outcomes, including procedural efficiency, safety, and long-term, effectiveness of catheter ablation with novel RF technologies in PAF and PsAF patients.
Primary Outcome
Freedom from arrhythmia recurrence at 90 days post procedure.
Conditions Studied
Interventions
- DEVICE Catheter ablation
Study Locations (20)
Florida
- Ascension St. Vincent's - Jacksonville
- HCA Florida Mercy Hospital - Miami
- Naples Community Hospital - Naples
- Ascension Sacred Heart - Pensacola
- Sarasota Memorial Hospital - Sarasota
- Baycare Health System - Winter Haven
California
- Keck School of Medicine - Los Angeles
- Santa Barbara Cottage Hospital - Santa Barbara
- Community Memorial Hospital - Ventura
- University HealthCare Alliance - Walnut Creek
Alabama
- University of Alabama at Birmingham - Birmingham
- Grandview Medical Center - Birmingham
- Cardiology Associates of Mobile - Mobile
Colorado
- The Medical Center of Aurora - Aurora
- Colorado Heart and Vascular - Golden
- South Denver Cardiology - Littleton
Georgia
- Piedmont Healthcare - Atlanta
- Memorial Health University Medical Center - Savannah
Arizona
- Valley Heart Rhythm Specialists - Chandler
Arkansas
- Arrhythmia Research Group - Jonesboro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15,000 participants |
| Start Date | 2018-01-01 |
| Est. Completion | 2027-12-31 |
What NCT04088071 shows while recruiting
NCT04088071 is an observational study that tracks outcomes without assigning an intervention. Its 15,000 participants enrollment target places it among the larger protocols in the corpus, above the 234-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (6310% higher).
The record links to 2 conditions, with Paroxysmal Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which Catheter ablation is the first listed.
NCT04088071 names 20 study sites across 7 states, led by Florida, California, Alabama.
Frequently Asked Questions
What is clinical trial NCT04088071 about?
NCT04088071 is a clinical study titled "Real-world Experience of Catheter Ablation for the Treatment of Paroxysmal and Persistent Atrial Fibrillation". The primary purpose of this registry is to obtain real-world clinical experience of Paroxysmal (PAF) and Persistent (PsAF) Atrial Fibrillation ablation radiofrequency (RF) technologies. Data from the registry will be used to assess clinical outcomes, including procedural efficiency, safety, and long...
What is the current status of trial NCT04088071?
This trial is currently recruiting. The enrollment target is 15,000 participants. The study started on 2018-01-01. Estimated completion is 2027-12-31.
What conditions does trial NCT04088071 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation.
What interventions are being tested in trial NCT04088071?
The interventions under investigation include: Catheter ablation (DEVICE).
Who is sponsoring clinical trial NCT04088071?
This trial is sponsored by Heart Rhythm Clinical and Research Solutions, which has 9 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04088071 being conducted?
This trial has 20 study locations across Alabama, Arizona, Arkansas, California, Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04088071's enrollment target sits among peer trials
15,000 1st of 24 higher than 24 of 24 other Paroxysmal Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Paroxysmal Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)
RECRUITING
-
STOP AF First Post-Approval Study
RECRUITING
-
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
RECRUITING
-
EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
RECRUITING
-
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
- NCT01137643 · 15,000 participants
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
- NCT01550575 · 15,000 participants
Patient Retrospective Outcomes (PRO)
- NCT02253251 · 15,000 participants
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI